- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Recombinant CD79a antibody is used to detect CD79a, a signaling protein that forms part of the B cell receptor complex. CD79a, also known as Ig alpha, pairs with CD79b to assemble the receptor module that transmits antigen recognition signals into the cell. It is expressed throughout B cell development and is indispensable for B cell activation, proliferation, and differentiation into antibody secreting cells. Because of this, CD79a is studied in immunology, oncology, and diagnostic pathology.
CD79a contains immunoreceptor tyrosine based activation motifs in its cytoplasmic domain. When antigen engages membrane immunoglobulin, these motifs are phosphorylated, leading to recruitment of kinases and activation of downstream pathways. This signaling cascade ensures that B cells respond appropriately to antigens and mount protective immune responses. The absence or dysfunction of CD79a impairs B cell survival and immune function.
The Recombinant CD79a antibody clone rIGA/764 provides precise and reproducible recognition of this receptor subunit. Recombinant technology ensures consistent performance across batches, which is essential for comparative studies. Clone rIGA/764 has been applied in developmental biology to trace B cell maturation and in oncology to identify B cell lymphomas. Its specificity makes it a dependable reagent for both basic research and clinical contexts.
Research using clone rIGA/764 has clarified how B cell receptor signaling governs adaptive immunity and how disruptions contribute to disease. Altered expression of CD79a is seen in certain immunodeficiencies and in malignancies such as chronic lymphocytic leukemia. The antibody also aids studies into therapeutic strategies that target B cell survival pathways.
NSJ Bioreagents supplies this Recombinant CD79a antibody to support studies of B cell development, signaling, and pathology. The protein is also described as Ig alpha antibody, mb1 antibody, CD79 alpha chain antibody, and B cell receptor signaling component antibody, reflecting the varied terminology used in research.
Optimal dilution of the recombinant CD79a antibody should be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
Recombinant human CD79a alpha chain protein was used as the immunogen for the recombinant CD79a antibody.
Store the recombinant CD79a antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.